Is LSB or DIVO a better dividend investment in 2026?

LSB currently yields 318.98% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: LSB offers higher current income.

What is the dividend yield difference between LSB and DIVO?

LSB has a forward dividend yield of 318.98% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 312.36 percentage points.

Home › Compare › LSB vs DIVO

LSB vs DIVO: Dividend Comparison 2026

LSB yields 318.98% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LSB wins by $2296.48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LSB

● Live price

318.98%

Share price

$0.63

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2296.51M

Annual income

$1,420,493,114.32

Full LSB calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — LSB vs DIVO

📍 LSB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LSB	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LSB + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LSB pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LSB

Annual income on $10K today (after 15% tax)

$27,113.24/yr

After 10yr DRIP, annual income (after tax)

$1,207,419,147.17/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, LSB beats the other by $1,207,418,289.97/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LSB + DIVO for your $10,000?

LSB: 50%DIVO: 50%

100% DIVO50/50100% LSB

Portfolio after 10yr

$1148.27M

Annual income

$710,247,061.40/yr

Blended yield

61.85%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LSB buys

DIVO buys

No recent congressional trades found for LSB or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLSBDIVO

Forward yield	318.98% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2296.51M ✓	$31.0K
Annual income after 10y	$1,420,493,114.32 ✓	$1,008.47
Total dividends collected	$2210.37M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LSB vs DIVO ($10,000, DRIP)

Year	LSB Portfolio	LSB Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$42,598	$31,897.93	$11,362	$661.96	+$31.2K → LSB
2	$172,569	$126,989.30	$12,860	$702.91	+$159.7K → LSB
3	$665,442	$480,792.73	$14,504	$743.56	+$650.9K → LSB
4	$2,444,714	$1,732,690.93	$16,303	$783.73	+$2.43M → LSB
5	$8,564,999	$5,949,155.42	$18,268	$823.31	+$8.55M → LSB
6	$28,643,738	$19,479,189.22	$20,408	$862.17	+$28.62M → LSB
7	$91,530,880	$60,882,080.00	$22,737	$900.20	+$91.51M → LSB
8	$279,758,876	$181,820,834.73	$25,266	$937.31	+$279.73M → LSB
9	$818,711,097	$519,369,100.17	$28,008	$973.42	+$818.68M → LSB
10	$2,296,513,989	$1,420,493,114.32	$30,977	$1,008.47	+$2296.48M → LSB

LSB vs DIVO: Complete Analysis 2026

LSB — Stock

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.

Full LSB Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this LSB vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LSB vs SCHD LSB vs JEPI LSB vs O LSB vs KO LSB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.